These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 38878186)
1. Disrupting Smad3 potentiates immunostimulatory function of NK cells against lung carcinoma by promoting GM-CSF production. Lian GY; Wang QM; Mak TS; Huang XR; Yu XQ; Lan HY Cell Mol Life Sci; 2024 Jun; 81(1):262. PubMed ID: 38878186 [TBL] [Abstract][Full Text] [Related]
2. Endogenous granulocyte-macrophage colony-stimulating factor overexpression in vivo results in the long-term recruitment of a distinct dendritic cell population with enhanced immunostimulatory function. Miller G; Pillarisetty VG; Shah AB; Lahrs S; Xing Z; DeMatteo RP J Immunol; 2002 Sep; 169(6):2875-85. PubMed ID: 12218100 [TBL] [Abstract][Full Text] [Related]
3. Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β. Brownlie D; Doughty-Shenton D; Yh Soong D; Nixon C; O Carragher N; M Carlin L; Kitamura T J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33472858 [TBL] [Abstract][Full Text] [Related]
4. Combination of Asiatic Acid and Naringenin Modulates NK Cell Anti-cancer Immunity by Rebalancing Smad3/Smad7 Signaling. Lian GY; Wang QM; Tang PM; Zhou S; Huang XR; Lan HY Mol Ther; 2018 Sep; 26(9):2255-2266. PubMed ID: 30017880 [TBL] [Abstract][Full Text] [Related]
5. TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells. Trotta R; Dal Col J; Yu J; Ciarlariello D; Thomas B; Zhang X; Allard J; Wei M; Mao H; Byrd JC; Perrotti D; Caligiuri MA J Immunol; 2008 Sep; 181(6):3784-92. PubMed ID: 18768831 [TBL] [Abstract][Full Text] [Related]
6. Enhanced Cancer Immunotherapy with Smad3-Silenced NK-92 Cells. Wang QM; Tang PM; Lian GY; Li C; Li J; Huang XR; To KF; Lan HY Cancer Immunol Res; 2018 Aug; 6(8):965-977. PubMed ID: 29915022 [TBL] [Abstract][Full Text] [Related]
7. NK cell-derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS. Louis C; Souza-Fonseca-Guimaraes F; Yang Y; D'Silva D; Kratina T; Dagley L; Hediyeh-Zadeh S; Rautela J; Masters SL; Davis MJ; Babon JJ; Ciric B; Vivier E; Alexander WS; Huntington ND; Wicks IP J Exp Med; 2020 May; 217(5):. PubMed ID: 32097462 [TBL] [Abstract][Full Text] [Related]
8. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor. Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038 [TBL] [Abstract][Full Text] [Related]
9. Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development. Tang PM; Zhou S; Meng XM; Wang QM; Li CJ; Lian GY; Huang XR; Tang YJ; Guan XY; Yan BP; To KF; Lan HY Nat Commun; 2017 Mar; 8():14677. PubMed ID: 28262747 [TBL] [Abstract][Full Text] [Related]
10. Self-carried nanodrug (SCND-SIS3): A targeted therapy for lung cancer with superior biocompatibility and immune boosting effects. Lian GY; Wan Y; Mak TS; Wang QM; Zhang J; Chen J; Wang ZY; Li M; Tang PM; Huang XR; Lee CS; Yu XQ; Lan HY Biomaterials; 2022 Sep; 288():121730. PubMed ID: 35995622 [TBL] [Abstract][Full Text] [Related]
11. Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production. Murphy JW; Zhou A; Wong SC Infect Immun; 1997 Nov; 65(11):4564-71. PubMed ID: 9353034 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo. Murphy WJ; Keller JR; Harrison CL; Young HA; Longo DL Blood; 1992 Aug; 80(3):670-7. PubMed ID: 1379086 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis. Roda JM; Sumner LA; Evans R; Phillips GS; Marsh CB; Eubank TD J Immunol; 2011 Aug; 187(4):1970-6. PubMed ID: 21765015 [TBL] [Abstract][Full Text] [Related]
14. Receptor modulation and functional activation of human CD34+ Lin- -derived immature NK cells in vitro by Mycobacterium bovis Bacillus Calmette-Guerin (BCG). Marras F; Bozzano F; Bentivoglio G; Ugolotti E; Biassoni R; Moretta L; De Maria A Eur J Immunol; 2012 Sep; 42(9):2459-70. PubMed ID: 22736333 [TBL] [Abstract][Full Text] [Related]
15. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
16. Sensitivity of dendritic cells to NK-mediated lysis depends on the inflammatory environment and is modulated by CD54/CD226-driven interactions. Smith LE; Olszewski MA; Georgoudaki AM; Wagner AK; Hägglöf T; Karlsson MC; Dominguez-Villar M; Garcia-Cozar F; Mueller S; Ravens I; Bernhardt G; Chambers BJ J Leukoc Biol; 2016 Oct; 100(4):781-789. PubMed ID: 27034402 [TBL] [Abstract][Full Text] [Related]
17. GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency. Ye P; Chen W; Wu J; Huang X; Li J; Wang S; Liu Z; Wang G; Yang X; Zhang P; Lv Q; Xia J J Clin Invest; 2013 May; 123(5):2317-31. PubMed ID: 23585475 [TBL] [Abstract][Full Text] [Related]
18. Macrophage lineage phenotypes and osteoclastogenesis--complexity in the control by GM-CSF and TGF-beta. Lari R; Fleetwood AJ; Kitchener PD; Cook AD; Pavasovic D; Hertzog PJ; Hamilton JA Bone; 2007 Feb; 40(2):323-36. PubMed ID: 17055352 [TBL] [Abstract][Full Text] [Related]
19. GM-CSF-secreting cancer immunotherapies: preclinical analysis of the mechanism of action. Simmons AD; Li B; Gonzalez-Edick M; Lin C; Moskalenko M; Du T; Creson J; VanRoey MJ; Jooss K Cancer Immunol Immunother; 2007 Oct; 56(10):1653-65. PubMed ID: 17410360 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of natural killer cell-mediated cytotoxicity by coexpression of GM-CSF/B70 in hepatoma. Kim KY; Kang MA; Nam MJ Cancer Lett; 2001 May; 166(1):33-40. PubMed ID: 11295284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]